Related references
Note: Only part of the references are listed.Biomarkers: optimizing treatment guidance in heart failure
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2011)
N-Terminal Pro-Brain Natriuretic Peptide Is a More Useful Predictor of Cardiovascular Disease Risk Than C-Reactive Protein in Older Men With and Without Pre-Existing Cardiovascular Disease
S. Goya Wannamethee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project
Stefan Blankenberg et al.
CIRCULATION (2010)
Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction
C. Meisinger et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement
Roman Pfister et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
The Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects
Paul M. McKie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
oA novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology
Jens Klotsche et al.
BMC MEDICAL RESEARCH METHODOLOGY (2009)
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Olle Melander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure
W. H. Wilson Tang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events
Tobias Simon et al.
CLINICAL RESEARCH IN CARDIOLOGY (2008)
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
Bjorn Zethelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
Michael H. Olsen et al.
EUROPEAN HEART JOURNAL (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Multiple biomarkers for the prediction of first major cardiovascular events and death
Thomas J. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes - Part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions
Victor J. Dzau et al.
CIRCULATION (2006)
Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study
Stefan Blankenberg et al.
CIRCULATION (2006)
Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes
M Weber et al.
CLINICAL RESEARCH IN CARDIOLOGY (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk factors in primary care:: methods and baseline prevalence rates -: the DETECT program
HU Wittchen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
TJ Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Overall C as a measure of discrimination in survival analysis:: model specific population value and confidence interval estimation
MJ Pencina et al.
STATISTICS IN MEDICINE (2004)
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
P Greenland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevalence of conventional risk factors in. patients with coronary heart disease
UN Khot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update - Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
TA Pearson et al.
CIRCULATION (2002)
The Malmo diet and cancer study:: representativity, cancer incidence and mortality in participants and non-participants
J Manjer et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2001)
Share Paper
